免费领取《2025中国合成生物制造产业发展白皮书》

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and sustainable practices [5]. Group 2: Policy Landscape - The report reviews major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025, providing insights into regulatory frameworks that could impact industry growth [5]. - It categorizes foreign and domestic policies, highlighting their implications for the biomanufacturing sector [5]. Group 3: Industry Map and Applications - A comprehensive map of the Chinese biomanufacturing industry is presented, detailing the key players and their roles within the ecosystem [5]. - The report identifies critical application areas for biomanufacturing, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises - The white paper lists the top 10 chain leader enterprises in China's biomanufacturing industry, providing a snapshot of the leading companies driving innovation and growth [6]. - It also details the strategic directions of 15 publicly listed companies in the synthetic biology space, summarizing their approaches to market opportunities [6]. Group 5: Investment and Challenges - The report discusses the investment landscape for synthetic biology in China, covering trends and funding activities from 2024 to mid-2025 [6]. - It addresses the challenges faced by the biomanufacturing industry in China, proposing targeted policy recommendations to overcome these obstacles [6].